Search Results
Site Search
April 2023 - Ophthalmic Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Ophthalmic Pathology.
Calprotectin and Inflammatory Bowel Disease - Insights
The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 14 - Insights
This week’s Research Roundup highlights how human gut-derived commensal bacteria suppresses central nervous system inflammatory and demyelinating disease.
Earth Day, Saturday, April 22, is one day when most folks pay particularly close attention to protecting the environment. This year, we're finding inspiration in the Sisters of Saint Francis who helped raise money for the Poverello Fund by...
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights
This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
Week in Review: October 4 - Insights
Top highlights include: Flu vaccine information, possible effects that red meat has on the human body, and what vaping does to the lungs.
Using CSI-Type Technology to Unravel the Source of Bacteria - Insights
Mayo Clinic laboratory workers have a new tool to perform high tech genetic sleuthing for the source of stubborn, sometimes life-threatening bacteria.
Mayo Clinic Laboratory and Pathology Research Roundup: July 16 - Insights
This week’s Research Roundup highlights how senolytics improve physical function and increase lifespan in old age.
Zooming in on Cancer Suspects - Insights
Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the "culprit" might be a rearrangement in a person's DNA, which genomic testing can capture. Mayo...
Revolutionizing Endometrial Cancer Diagnostics - Insights
Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...
Hospitals and health systems - Insights
Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.
A decade-long search for answers ends at Mayo Clinic: Tyler Hart - Insights
After years of misdiagnosis, Tyler Hart found answers at Mayo Clinic, discovering he had NF155-IgG4 autoimmune nodopathy instead of CIDP
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Preparation of Platelet-Poor Plasma for Special Coagulation Testing - Insights
In this months "Hot Topic," Christopher Desens, MLS(ASCP) discusses the preparation of platelet-poor plasma for coagulation testing.
Pathways Case Studies: October 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for October include the following sub-specialties Breast Pathology, Gynecological...
Innovative Alzheimer's disease diagnostic tool unveiled - Insights
Mayo Clinic Laboratories has marked a significant advancement in the fight against Alzheimer's disease with the introduction of an innovative diagnostic test. This noninvasive blood test accurately detects the p-Tau217 biomarker, indicative...
Helicobacter pylori - Insights
Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Malabsorption panel - Insights
Mayo Clinic Laboratories, which is integrated with the clinical gastroenterology practice at Mayo Clinic, understands the worry patients and their loved ones feel while awaiting test results. To expedite and streamline the diagnostic...
Comprehensive neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.
Bobbi Pritt, M.D., on Asian Longhorned Tick in U.S - Insights
According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and...
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Sarcoma NGS Testing - Mayo Clinic Laboratories
n order to aid in the diagnosis for a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes.
Nuclear Magnetic Resonance Lipoprotein Profile [Test in Focus] - Insights
Jeffrey (Jeff) Meeusen, Ph.D., gives an overview of the new nuclear magnetic resonance (NMR) lipoprotein profile available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon...
Autoimmune Myelopathy Evaluation [Test in Focus] - Insights
Patients with autoimmune myelopathy present with subacute onset and rapid progression of spinal cord symptoms (weakness, gait difficulties, loss of sensation, neuropathic pain, and bowel and bladder dysfunction). Autoimmune myelopathy...
Holiday Specimen Shipment - Insights
Due to the Independence Day holiday (recognized on Saturday, July 4), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
Allan Jaffe, M.D., Discusses Effect of Highly Sensitive Cardiac Troponin in Healio - Insights
High-sensitivity cardiac troponin levels are strongly associated with the risk for incident heart failure. Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in...
Tips & Tricks for Difficult Sticks - Insights
This "Phlebotomy webinar" focuses on the origins of difficult collections and the situations that result in them.
Necrotizing Autoimmune Myopathy [Test in Focus] - Insights
Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase...
CPT Codes and LOINC Update: May 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May 2019.
Krabbe disease added to federal newborn screening panel - Insights
Thanks to advocacy work by a group of medical experts, including some from Mayo Clinic, the U.S. Department of Health and Human Services now recommends all states screen for infantile Krabbe disease to help save newborn lives.
Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights
Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...
Blood Diversion/Culture Contamination - Insights
PACE/State of FL - Blood diversion as a mechanism to lower blood culture contamination rates.
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
The standard test for the diagnosis of narcolepsy is the multiple sleep latency test (MSLT). The MSLT is a complex test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT...
Bobbi Pritt, M.D., Discusses Hookworms with The Washington Post - Insights
The Washington Post recently reported on hookworms burrowing into a teenager's skin during a trip to Florida. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services at Mayo Clinic,...
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 3 - Insights
This week’s Research Roundup highlights predicting renal function outcomes after partial and radical nephrectomy.
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Inflammatory bowel disease - Insights
Our robust menu of inflammatory bowel disease (IBD) testing can assist with the diagnosis and management of IBD and includes first-line fecal testing for calprotectin; serologic analysis of clinically relevant antibodies; and genetic...
Urinary stone services - Insights
Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.
On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease predictions for 2017.
Bobbi Pritt, M.D., Discusses Safe Tick Removal - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, discussed how to safety remove ticks from skin with AccuWeather.com.
MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732
MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular
People Archives - Page 10 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
The Adoption of Social Media in Education - Insights
Elissa Hall, Associate Director for Curriculum and Education Technology and an Assistant Professor at Mayo Clinic, discusses how the adoption of social media in education creates a flexible environment for facilitating collaborative, deeper...
Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...
Genetic Testing for Inherited Cardiovascular Disorders - Insights
In this month's "Hot Topic," Linnea Baudhuin, Ph.D., discusses Mayo Clinic Laboratories’ up-to-date gene panel tests for cardiomyopathies and arrhythmias, connective tissue and vascular fragility disorders, dyslipidemias, and congenital...
Learn more about Mayo Clinic Laboratories testing for pregnancy loss, which can help determine causes and risk of recurrence for future pregnancies.
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
With the rise of next generation sequencing (NGS) technology, multigene panel testing is expanding so rapidly that clinical practice is racing to keep pace. And questions within genetic tests have expanded along with it, making definitive...
Beyond the Test Result: Greg Widseth - Insights
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...